Increased risk for developing a psychological illness, CVD at one year seen after family member”s cancer diagnosis
MONDAY, Sept. 9, 2024 (HealthDay News) — Cancer diagnosis is associated with an increased risk for psychological illness and cardiovascular disease among first-degree relatives and spouses of patients, according to a study published online Sept. 9 in Cancer.
Using data from the Utah Population Database, Mouneeb M. Choudry, M.D., from the Mayo Clinic in Phoenix, and colleagues conducted a retrospective cohort analysis to examine the risk for psychological illness and cardiovascular disease in first‐degree relatives and spouses of patients diagnosed with a genitourinary cancer between 1990 and 2015 compared to relatives of those without a genitourinary cancer.
A total of 49,284 patients with a genitourinary cancer were identified, with 77,938 first-degree relatives and spouses; 246,775 patients with 81,022 first‐degree relatives and spouses were included in the matched control group. The researchers found that at one year after a family member”s cancer diagnosis, there was an increased risk for developing psychological illness and cardiovascular disease (hazard ratios [95 percent confidence intervals], 1.10 [1.00 to 1.20] and 1.28 [1.17 to 1.41], respectively).
“As health care professionals, we should take a multidisciplinary approach to addressing the stress of a cancer diagnosis by helping mitigate financial toxicity, treatment burden, and emotional impact on both the patient and their family,” Choudry said in a statement.
Aircrew Face Higher Odds of Radiation-Related Cancer Deaths
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors
Couples" Coping Skills Help Reduce Depression in GI Cancer Survivors
Genomic Newborn Screening Could ID Cancer Predisposition Syndrome
Patient Education Increases Skin Cancer Screening in Stem Cell Transplant Survivors
Real-World ARIA Incidence With Lecanemab Aligns With Clinical Trial Findings
Subclinical Cardiac Dysfunction Linked to Neurodegeneration in APOE-ε4 Carriers
Study IDs Gaps in Hereditary Breast Cancer Risk Assessment Before Gender-Affirming Mastectomy